RZLT Rezolute
- 2.650
- -0.030-1.12%
- 2.650
- 0.0000.00%
Rezolute News
Rezolute | 10-Q: Quarterly report
Rezolute 1Q R&D Expenses $12.4M >RZLT
Rezolute 1Q R&D Expenses $12.4M >RZLT
Rezolute 3Q Loss/Shr 34c >RZLT
Rezolute 3Q Loss/Shr 34c >RZLT
Press Release: Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update Patient enrollment underway in sunRIZE global Phase 3 clinical study of RZ358 in patients with congenital hyp
Rezolute to Present Phase 2 RIZE Study at PES Meeting
Phase 2 RIZE Study Sub-Analyses To Be Presented At 2024 Pediatric Endocrine Society Annual Meeting
Phase 2 RIZE Study Sub-Analyses To Be Presented At 2024 Pediatric Endocrine Society Annual Meeting
J.P. Morgan Securities: Rezolute (RZLT.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $7.00.
J.P. Morgan Securities: Rezolute (RZLT.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $7.00.
JMP Securities Reiterates Market Outperform on Rezolute, Maintains $7 Price Target
JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:RZLT) with a Market Outperform and maintains $7 price target.
Rezolute Initiated at Buy by JonesTrading
Rezolute Initiated at Buy by JonesTrading
JonesTrading Initiates Coverage On Rezolute With Buy Rating, Announces Price Target of $10
JonesTrading analyst Catherine Novack initiates coverage on Rezolute with a Buy rating and announces Price Target of $10.
Optimistic Buy Rating for Rezolute's RZ402 Drug Candidate Amid Promising DME Treatment Prospects
Rezolute Initiated at Buy by Maxim Group
Rezolute Initiated at Buy by Maxim Group
Rezolute (RZLT.US) was first covered by Maxim Group and given a buy rating, with a target price of $8.00.
Rezolute (RZLT.US) was first covered by Maxim Group and given a buy rating, with a target price of $8.00.
Maxim Group Initiates Coverage On Rezolute With Buy Rating, Announces Price Target of $8
Maxim Group analyst Jason McCarthy initiates coverage on Rezolute with a Buy rating and announces Price Target of $8.
CommScope Holding And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte
Rezolute(RZLT.US) Officer Buys US$1,275 in Common Stock
$Rezolute(RZLT.US)$ Officer ROBERTS BRIAN KENNETH purchased 500 shares of Common Stock on Mar 28, 2024 at an average price of $2.55 for a total value of $1,275.Source: Announcement What is statement o
$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders i
Rezolute(RZLT.US) Officer Buys US$33,830 in Common Stocks
$Rezolute(RZLT.US)$ Officer Evans Daron purchased 20,000 shares of Common Stocks on Mar 15, 2024 at an average price of $1.6915 for a total value of $33,830.Source: Announcement What is statement of c
Rezolute(RZLT.US) Officer Buys US$18,800 in Common Stocks
$Rezolute(RZLT.US)$ Officer ROBERTS BRIAN KENNETH purchased 10,000 shares of Common Stocks on Mar 14, 2024 at an average price of $1.88 for a total value of $18,800.Source: Announcement What is statem
(SEC Amendment) Rezolute(RZLT.US) Officer Buys US$925 in Common Stocks
$Rezolute(RZLT.US)$ Officer ROBERTS BRIAN KENNETH purchased 500 shares of Common Stocks on Mar 7, 2024 at an average price of $1.85 for a total value of $925.Source: Announcement What is statement of
Analysis
Price Target
No Data
